Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
4.430
+0.600 (15.67%)
At close: Jul 3, 2025, 1:00 PM
4.380
-0.050 (-1.13%)
After-hours: Jul 3, 2025, 4:59 PM EDT
Vivos Therapeutics Market Cap
Vivos Therapeutics has a market cap or net worth of $26.09 million as of July 3, 2025. Its market cap has increased by 274.68% in one year.
Market Cap
26.09M
Enterprise Value
25.15M
1-Year Change
274.68%
Ranking
Category
Stock Price
$4.43
Market Cap Chart
Since the IPO on December 11, 2020, Vivos Therapeutics's market cap has decreased from $103.52M to $26.09M, a decrease of -74.80%. That is a compound annual growth rate of -26.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 26.09M | 3.26% |
| Dec 31, 2024 | 25.27M | 69.64% |
| Dec 29, 2023 | 14.89M | 61.00% |
| Dec 30, 2022 | 9.25M | -82.13% |
| Dec 31, 2021 | 51.78M | -50.41% |
| Dec 31, 2020 | 104.41M | 0.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 306.47B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 238.56B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 216.08B |